Indomethacin sodium

吲哚美辛钠

Report date: 2024/04/01 10:56:58
NME

Base Information

Drug NameIndomethacin sodium
Drug Alias NameIndometacin sodiumIndocin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsInflammationDuctus Arteriosus, Patent
Global Approved IndicationsInflammationDuctus Arteriosus, Patent
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1965/12/31
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsDuctus Arteriosus, Patent
Inactive IndicationsInflammation

Other Information

ATC CodeC01EB03M01AB01M02AA23 +[4